If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...

An addiction recovery group plans to increase its presence in downtown Manchester as part of an effort to address the ...

A Code Blue emergency declaration adds another layer of urgency to the work being done by homeless outreach groups throughout ...

Despite concerns over cabozantinib's patent expiry, Exelixis projects robust future revenues, with lead pipeline candidate ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

After years of lending and investing in South Florida, Michael Dell’s BDT & MSD Partners is now looking to get into ...

Company operates in the pharmaceutical and data centre sectors and is to expand it offerings to the electric vehicle battery ...

Prime Minister Narendra Modi on Thursday announced the completion of the Genome India project, which makes available database ...